本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ALX Oncology Holdings

1.94
+0.04002.11%
盤後1.970.0300+1.55%19:30 EDT
成交量:103.64萬
成交額:201.07萬
市值:2.68億
市盈率:-1.69
高:2.01
開:1.91
低:1.85
收:1.90
52周最高:2.66
52周最低:1.01
股本:1.38億
流通股本:9,474.24萬
量比:1.64
換手率:1.09%
股息:- -
股息率:- -
每股收益(TTM):-1.1500
每股收益(LYR):-1.9000
淨資產收益率:-80.65%
總資產收益率:-40.40%
市淨率:1.97
市盈率(LYR):-1.02

資料載入中...

2021/03/18

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/18

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/18

重要事件披露

8-K - Current report
2021/03/15

重要事件披露

8-K - Current report
2020/12/23

重要事件披露

8-K - Current report
2020/12/07

SEC問詢函

CORRESP [Cover] - Correspondence
2020/12/07

SEC問詢函

CORRESP [Cover] - Correspondence
2020/12/07

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2020/11/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/12

重要事件披露

8-K - Current report
2020/10/01

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/08/27

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/27

重要事件披露

8-K - Current report
2020/08/26

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/07/31

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/07/29

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/07/21

重要事件披露

8-K - Current report
2020/07/17

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/07/13

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/06/26

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933